Development of histopathological methodology without staining using a spectroscopy

Development of histopathological methodology without staining using a spectroscopy - NOn-staining histopathological methodology using a spectroscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017045

Enrollment

250

Registered

2015-04-04

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal, gastric, colorectal, hepatic, pancreatic, bile duct, and gallbladder cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) patients with histologically proven cancer. And benign disease patients without cancer. (2) age 20-80 years. (3) Eastern Cooperative Oncology Group. performance status 0 or 1. (4) sufficient organ function. (5) written informed consent.

Exclusion criteria

Exclusion criteria: (1) synchronous or metachronous malignancy. (2) pregnant or breastfeeding women.

Design outcomes

Primary

Measure	Time frame
Accuracy of diagnosis of cancer cells by spectroscopy.	—

Countries

Japan

Contacts

Public ContactHiroaki Ito

Showa University Koto Toyosu Hospital Advanced Cancer Translational Research Institute

h.ito@med.showa-u.ac.jp03-3784-8145

Outcome results